PCN140 - Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain
| Autor: | Garcia Lopez, J.L., Rodriguez, Barrios J.M., Puig-Junoy, J., Carrato, Mena A. |
|---|---|
| Zdroj: | In Value in Health November 2014 17(7):A638-A638 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect